Publicaciones en colaboración con investigadores/as de University of California, San Francisco (36)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3063-3071

2022

  1. Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options

    Updates in Surgery, Vol. 74, Núm. 1, pp. 325-335

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  3. Scientists Against War: A Plea to World Leaders for Better Governance

    Sleep and Vigilance

2021

  1. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    Nature Communications, Vol. 12, Núm. 1

  2. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

    Nature Communications, Vol. 12, Núm. 1

  3. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information

    Nature Communications, Vol. 11, Núm. 1

  2. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update

    Journal of Clinical Oncology, Vol. 38, Núm. 5, pp. 496-520

2019

  1. Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry

    European Heart Journal, Vol. 40, Núm. 35, pp. 2964-2975A

  2. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset

    npj Parkinson's Disease, Vol. 5, Núm. 1

  3. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability

    npj Parkinson's Disease, Vol. 5, Núm. 1

  4. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

    Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344

  5. Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 1, pp. 359-368

2018

  1. Cohort profile: Pregnancy and childhood epigenetics (PACE) consortium

    International Journal of Epidemiology, Vol. 47, Núm. 1, pp. 22-23u

  2. Early retinal atrophy predicts long-term visual impairment after acute optic neuritis

    Multiple Sclerosis Journal, Vol. 24, Núm. 9, pp. 1196-1204

2017

  1. Transancestral mapping and genetic load in systemic lupus erythematosus

    Nature Communications, Vol. 8

2016

  1. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 242-252